Cannibics Pharmaceuticals (QB) Stock Price

-0.0175 (-9.83%)


52 Week Range


Best deals to access real time data!
Small Cap Basic
Monthly Subscription
for only
Ultimate Trader (Monthly)
Monthly Subscription
for only
DDE w/Realtime (Monthly)
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Cannibics Pharmaceuticals Inc (QB) CNBX OTCMarkets Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.0175 -9.83% 0.1605 16:30:18
Open Price Low Price High Price Close Price Prev Close
0.178 0.1605 0.185 0.1605 0.178
Bid Price Ask Price Spread News
0.155 0.1955 0.0405 - -
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
144 686,324 $ 0.17815 $ 122,268 - 0.135 - 0.60
Last Trade Time Type Quantity Stock Price Currency
15:50:23 2,000 $ 0.1605 USD

Cannibics Pharmaceuticals (QB) Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 22.33M 139.15M 47.53M $ - $ - - -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
1.41M $ - 0.00% - -

more financials information »

Cannibics Pharmaceuticals (QB) News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical CNBX Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.250.28940.16040.2099099801,224-0.0895-35.8%
1 Month0.360.360.16040.2419618457,515-0.1995-55.42%
3 Months0.330.600.16040.3706615528,698-0.1695-51.36%
6 Months0.15350.600.1450.3256862396,6860.0074.56%
1 Year0.300.600.1350.3027551262,808-0.1395-46.5%
3 Years1.061.350.0660.4290792259,967-0.8995-84.86%
5 Years0.07797.600.02251.20355,2080.0826106.03%

Cannibics Pharmaceuticals (QB) Description

Cannabics Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company specializing in the discovery, development and commercialization of novel cannabinoid-based products and innovative technologies for the treatment of cancer. We combine the power of our proprietary technologies with the expertise of our leading scientists to unlock the medicinal properties of cannabis and its diversity of bioactive compounds. We have conducted thousands of tests on biopsies and cell lines in order to identify the physiologic impact of cannabinoids on cell cycle and cell death. Our core technology is a continuously evolving bioinformatics platform that utilizes high throughput screening technology, advanced data analytics, artificial intelligence and proprietary methodologies to rapidly examine the physiologic impact of multiple cannabinoid compounds on tumor cells.

Your Recent History
Cannibics ..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.